Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Solid Biosciences (SLDB)

Tipranks - Thu Apr 16, 5:58AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker (SYK) and Solid Biosciences (SLDB) with bullish sentiments.

Claim 30% Off TipRanks

Stryker (SYK)

Citi analyst Joanne Wuensch maintained a Buy rating on Stryker today and set a price target of $385.00. The company’s shares closed last Tuesday at $345.88.

According to TipRanks.com, Wuensch is a 3-star analyst with an average return of 1.3% and a 50.4% success rate. Wuensch covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Establishment Labs Holdings, and Bausch + Lomb Corporation. ;'>

Currently, the analyst consensus on Stryker is a Strong Buy with an average price target of $425.10, implying a 22.2% upside from current levels. In a report issued on April 13, Leerink Partners also initiated coverage with a Buy rating on the stock with a $410.00 price target.

See today’s best-performing stocks on TipRanks >>

Solid Biosciences (SLDB)

In a report released today, Gil Blum from Needham maintained a Buy rating on Solid Biosciences, with a price target of $19.00. The company’s shares closed last Tuesday at $8.23.

According to TipRanks.com, Blum is a 4-star analyst with an average return of 9.1% and a 40.2% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., Recursion Pharmaceuticals, and Mereo Biopharma Group Plc. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Solid Biosciences with a $17.86 average price target.

Read More on SYK:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.